Multiple myeloma in a resource constrained setting

Adding daratumumab to VRd shows better efficacy outcomes compared to VRd alone in multiple myeloma

Global Coalition for Radiotherapy - How to integrate radiotherapy in cancer control plans

Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results

Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS compared to trifluridine/tipiracil monotherapy in mCRC

Pembrolizumab a promising option for MIUC patients after radical surgery

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Updates on lung cancer from WCLC and ESMO 2023

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems

Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis

Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC

Cabozantinib and atezolizumab show more efficacy compared to second NHT in patients with mCRPC